Ria Advisory Group LLC Incyte Corp Transaction History

Ria Advisory Group LLC

  • $283 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$57.77 - $65.93 $5,834 - $6,658
101 Added 2.39%
4,322 $250 Million
Q2 2023

Jul 25, 2023
BUY
$60.95 - $75.51 $29,316 - $36,320
481 Added 12.86%
4,221 $263 Million
Q1 2023

Apr 25, 2023
BUY
$70.23 - $86.01 $262,660 - $321,677
3,740 New
3,740 $272 Million

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ria Advisory Group LLC Portfolio

Follow Ria Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ria Advisory Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email